Myeloid-mediated immunotherapy resistance in prostate cancer
Personalised dynamic prediction model in active surveillance
Sequencing cabazitaxel and 177Lu-PSMA-617
10-year outcomes of stereotactic radiation therapy
Natural history of PIRADS-2 lesions
Immune response after irreversible electroporation
Risk stratification of high-risk and locoregional prostate cancer
Gene expression classifier and adjuvant treatment after radical prostatectomy
Biparametric vs multiparametric MRI
Pelvic lymph node dissection in prostate cancer
Please login below to download this issue (PDF)